Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice

Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice

Autor Silva, R. H. Google Scholar
Kameda, SR Google Scholar
Carvalho, R. C. Google Scholar
Takatsu-Coleman, A. L. Google Scholar
Niigaki, S. T. Google Scholar
Abilio, V. C. Google Scholar
Tufik, S. Google Scholar
Frussa, R. Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Rationale: Several clinical studies demonstrate that the absence of periods of sleep is closely related to occurrence of anxiety symptoms. However, the basis of these interactions is poorly understood. Studies performed with animal models of sleep deprivation and anxiety would be helpful in the understanding of the mechanisms underlying this relationship, but some animal studies have not corroborated clinical data, reporting anxiolytic effects of sleep deprivation. Objectives: the aim of the present study was to verify the effects of different protocols of sleep deprivation in mice tested in the elevated plus-maze and to assess the effect of chlordiazepoxide and clonidine. Methods: Three-month-old male mice were sleep-deprived for 24 or 72 h using the methods of single or multiple platforms in water tanks. Mice kept in their home cages were used as controls. Plus-maze behavior was observed immediately after the deprivation period. Results: Mice that were sleep-deprived for 72 h spent a lower percent time in the open arms of the apparatus than control animals. This sleep deprivation-induced anxiety-like behavior was unaffected by treatment with chlordiazepoxide (5.0 and 7.5 mg/kg IP), but reversed by an administration of 5 or 10 mug/kg IP clonidine. Conclusion: the results indicate that under specific methodological conditions sleep deprivation causes an increase in anxiety-like behavior in mice exposed to the elevated plus-maze.
Palavra-chave sleep deprivation
anxiety
animal model
chlordiazepoxide
clonidine
Idioma Inglês
Data de publicação 2004-11-01
Publicado em Psychopharmacology. New York: Springer, v. 176, n. 2, p. 115-122, 2004.
ISSN 0033-3158 (Sherpa/Romeo, fator de impacto)
Publicador Springer
Extensão 115-122
Fonte http://dx.doi.org/10.1007/s00213-004-1873-z
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000224752400001
Endereço permanente http://repositorio.unifesp.br/handle/11600/27997

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta